Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative
RNA-based therapeutics, will report third quarter 2014 financial results
before the NASDAQ Global Market opens on Thursday, November 6, 2014.
Subsequently, at 8:00 a.m. Eastern Time, Chris Garabedian, Sarepta’s
president and chief executive officer, and Sandy Mahatme, Sarepta’s
... read more